{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:51:43Z","timestamp":1786985503197,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.breast.2023.03.005","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T17:32:32Z","timestamp":1678296752000},"page":"281-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Tailored axillary surgery \u2013 A novel concept for clinically node positive breast cancer"],"prefix":"10.1016","volume":"69","author":[{"given":"Martin","family":"Heidinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Knauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Tausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter P.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2023.03.005_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0011-3840(70)80007-7","article-title":"The surgical dilemma in the primary therapy of invasive breast cancer: a critical appraisal","volume":"7","author":"Fisher","year":"1970","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.breast.2023.03.005_bib2","first-page":"3863","article-title":"Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture","volume":"40","author":"Fisher","year":"1980","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2023.03.005_bib3","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.breast.2021.08.018","article-title":"Axillary surgery in node-positive breast cancer","volume":"62","author":"Maggi","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.breast.2023.03.005_bib4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM198503143121102","article-title":"Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation","volume":"312","author":"Fisher","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2023.03.005_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1200\/JCO.2004.12.108","article-title":"Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up","volume":"22","author":"Louis-Sylvestre","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2023.03.005_bib7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.breast.2023.03.005_bib10","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","author":"Bartels","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the Optimal Treatment of the Axilla \u2013 surgery or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"S\u00e1volt","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib12","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sol\u00e1","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib14","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1245\/s10434-022-11866-w","article-title":"Preservation of axillary lymph nodes compared with complete dissection in T1\u20132 breast cancer patients presenting one or two metastatic sentinel lymph nodes: the SINODAR-ONE multicenter randomized clinical trial","volume":"29","author":"Tinterri","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","article-title":"Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase","volume":"99","author":"Goyal","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2023.03.005_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","article-title":"Sentinel lymph node biopsy in breast cancer","volume":"251","author":"Veronesi","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2023.03.005_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.soc.2006.10.015","article-title":"Sentinel node mapping for breast cancer: progress to date and prospects for the future","volume":"16","author":"Mabry","year":"2007","journal-title":"Surg Oncol Clin"},{"key":"10.1016\/j.breast.2023.03.005_bib18","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1245\/s10434-011-1688-1","article-title":"Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema","volume":"18","author":"Goldberg","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(20)31953-X","article-title":"Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial","volume":"396","author":"Mittendorf","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2023.03.005_bib22","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S1470-2045(18)30570-9","article-title":"Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial","volume":"19","author":"van Ramshorst","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2023.03.005_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030521","article-title":"Pathological response in the breast and axillary lymph nodes after neoadjuvant systemic treatment in patients with initially node-positive breast cancer correlates with disease free survival: an exploratory analysis of the GeparOcto trial","volume":"14","author":"Gerber","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.breast.2023.03.005_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4048\/jbc.2022.25.e17","article-title":"Relationship between breast and axillary pathologic complete response according to clinical nodal stage: a nationwide study from Korean breast cancer society","volume":"25","author":"Ryu","year":"2022","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.breast.2023.03.005_bib26","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1245\/s10434-021-10519-8","article-title":"Relationship between breast and axillary pathologic complete response in women receiving neoadjuvant chemotherapy for breast cancer","volume":"28","author":"Lim","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2023.03.005_bib28","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.breast.2023.03.005_bib29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071565","article-title":"Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the EUBREAST-03 AXSANA study","volume":"13","author":"Banys-Paluchowski","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.breast.2023.03.005_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","author":"Kuemmel","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2023.03.005_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.clbc.2017.04.006","volume":"17","author":"van Nijnatten","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2023.03.005_bib35","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS20-GS1-10","article-title":"Abstract GS1-10: radioactive Iodine Seed placement in the Axilla with Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results of the prospective multicenter RISAS trial","volume":"81","author":"Simons","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2023.03.005_bib36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/bjs\/znaa083","article-title":"Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial","volume":"108","author":"Hartmann","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/j.breast.2023.03.005_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071539","article-title":"The evolving role of marked lymph node biopsy (Mlnb) and targeted axillary dissection (tad) after neoadjuvant chemotherapy (nact) for node\u2010positive breast cancer: systematic review and pooled analysis","volume":"13","author":"Swarnkar","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.breast.2023.03.005_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2023.03.005_bib39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/bjs.10555","article-title":"Combined PET\u2013CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy","volume":"104","author":"Koolen","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.breast.2023.03.005_bib40","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1245\/s10434-018-6404-y","article-title":"Major reduction in axillary lymph node dissections after neoadjuvant systemic therapy for node-positive breast cancer by combining PET\/CT and the MARI procedure","volume":"25","author":"van der Noordaa","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","article-title":"Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer","volume":"157","author":"Simons","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2023.03.005_bib43","doi-asserted-by":"crossref","first-page":"TPS600","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS600","volume":"37","author":"Mamounas","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib44","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS21-OT1-04-01","volume":"82","author":"Goyal","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2023.03.005_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10549-017-4405-3","article-title":"Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients","volume":"166","author":"Ahmed","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2023.03.005_bib46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1245\/s10434-020-08928-2","article-title":"Omission of axillary lymph node dissection is associated with inferior survival in breast cancer patients with residual N1 nodal disease following neoadjuvant chemotherapy","volume":"28","author":"Almahariq","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib47","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2020.38.15_suppl.572","article-title":"Impact of axillary lymph node dissection (ALND) on survival in patients with ypN1 breast cancer that receive regional nodal irradiation (RNI): a national cancer database (NCDB) analysis","volume":"38","author":"Kharouta","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-022-06545-z","article-title":"Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol","volume":"193","author":"van Loevezijn","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2023.03.005_bib49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-022-06610-7","article-title":"Axillary radiation alone is a suboptimal treatment for ypN + in patients with triple negative breast cancer and axillary lymph node dissection should be considered in this setting","volume":"194","author":"Swarnkar","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2023.03.005_bib51","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s13063-018-3021-9","article-title":"Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial","volume":"19","author":"Henke","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.breast.2023.03.005_bib52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.breast.2021.09.004","article-title":"Tailored axillary surgery in patients with clinically node-positive breast cancer: pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23\/16, IBCSG 57-18, ABCSG-53, GBG 101)","volume":"60","author":"Weber","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.breast.2023.03.005_bib53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2023.03.005_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2023.03.005_bib55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2023.03.005_bib56","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1245\/s10434-020-09228-5","article-title":"Assessing the burden of nodal disease for breast cancer patients with clinically positive nodes: hope for more limited axillary surgery","volume":"28","author":"Angarita","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib57","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1245\/s10434-021-09943-7","article-title":"Palpable adenopathy does not indicate high-volume axillary nodal disease in hormone receptor-positive breast cancer","volume":"28","author":"Crown","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib58","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.00173","article-title":"Impact of RxPONDER and monarchE on the surgical management of the axilla in patients with breast cancer","author":"Mittendorf","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib59","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.20.02514","article-title":"Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR1, HER22, node-positive, high-risk, early breast cancer (monarchE)","volume":"38","author":"Johnston","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.03.005_bib60","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2023.03.005_bib61","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2023.03.005_bib62","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2023.03.005_bib63","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2023.03.005_bib64","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2023.03.005_bib65","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamasurg.2019.1742","article-title":"Factors associated with lymphedema in women with node-positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection","volume":"154","author":"Armer","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2023.03.005_bib66","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1200\/JCO.2010.28.2491","article-title":"Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: national Surgical Adjuvant Breast and Bowel Project phase III protocol B-32","volume":"28","author":"Land","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:46:45Z","timestamp":1760777205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977623000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":62,"alternative-id":["S0960977623000619"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2023.03.005","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tailored axillary surgery \u2013 A novel concept for clinically node positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2023.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}